Overview

Ondansetron Reduce Vomiting Associated With Ketamine PSA

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
0
Participant gender:
All
Summary
Ondansetron, a commonly used anti-vomiting medication, may reduce the occurrence of vomiting associated with ketamine during procedural sedation in the pediatric emergency department.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Ketamine
Ondansetron
Criteria
Inclusion Criteria:

- age 1-21 years, ASA I or II, fracture of dislocation reduction

Exclusion Criteria:

- age < 1 year, ASA III or IV, hypertension, glaucoma, acute globe injury, increased
intracranial pressure or central nervous system mass lesion, major psychiatric
disorder, porphyria, previous adverse reaction to ketamine or ondansetron, parent,
guardian or patient unwilling to provide informed consent.